Fundamental dimension Equity attribute | AWKPeer $142.75▼-0.34% Cap $28.37BP/E 24.7x QuantScore41/100 | ARTNAPeer $34.10▲+0.26% Cap $352.2MP/E 14.8x QuantScore42/100 | AWRLeader $85.44▲+0.46% Cap $3.39BP/E 23.3x QuantScore43/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
83/100 |
82/100 |
84/100 |
Valuation Multiples, PEG & DCF upside | 38/100 | 43/100 | 40/100 |
Health Piotroski, Altman Z, leverage & liquidity | 21/100 | 28/100 | 33/100 |
Growth Revenue / earnings growth & margins | 33/100 | 26/100 | 41/100 |
Sentiment Analyst ratings, targets & revisions | 31/100 | 33/100 | 15/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 24.7x | 14.8x | 23.3x |
Forward P/E (next FY) | 23.5x | 15.0x | 23.3x |
EV / EBITDA (TTM) | 15.4x | 9.7x | 15.9x |
Price / Sales | 5.4x | 3.0x | 4.9x |
Price / Free Cash Flow | -27.5x | 87.9x | 163.2x |
PEG ratio | 5.96 | 2.47 | 1.96 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 6 / 9 | 5 / 9 | 6 / 9 |
Altman Z-Score | 1.07 (Distress) | 0.78 (Distress) | 2.06 (Grey) |
Total debt / equity | 1.38 | 0.72 | 0.71 |
Quick ratio | 0.5x | 1.0x | 0.9x |
Interest coverage | 3.0x | 4.2x | 4.7x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +9.7% | +4.6% | +10.5% |
Net income growth YoY | +5.7% | +11.9% | +9.4% |
Gross margin (TTM) | 47.2% | 37.3% | 57.0% |
Operating margin (FY) | 36.6% | 31.5% | 30.9% |
FCF margin (FY) | -20.8% | -16.4% | -1.1% |
5. Trailing price performancePrice change over period |
1M return | +9.0% | +2.6% | +3.2% |
3M return | +6.0% | -1.0% | -1.1% |
6M return | +7.8% | +6.3% | +7.6% |
Year to date | +9.4% | +7.9% | +17.9% |
1Y return | +3.4% | +1.5% | +12.3% |
3Y return | +22.5% | -13.3% | +11.2% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $-288.95 -302.4% premium | $-112.37 -429.5% premium | $-5.60 -106.6% premium |
Wall Street consensus target | $139.67 -2.2% · range $127.00–$153.00 | — — | $89.50 +4.8% · range $87.00–$92.00 |
Consensus stance | 47% Buy47% Hold7% Sell | 50% Buy50% Hold0% Sell | 20% Buy50% Hold30% Sell |